Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma

References

• ESMO/European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2014;25 Suppl 3:iii102–12
   PubMed Web of Science ®Google Scholar
• Clarkson P, Ferguson PC. Primary multidisciplinary management of extremity soft tissue sarcomas. Curr Treat Options Oncol 2004;5:451–62
   PubMedGoogle Scholar
• Andreou D, Boldt H, Pink D, Jobke B, Werner M, Schuler M, et al. Prognostic relevance of 18F-FDG PET uptake in patients with locally advanced, extremity soft tissue sarcomas undergoing neoadjuvant isolated limb perfusion with TNF-alpha and melphalan. Eur J Nucl Med Mol Imaging 2014;41:1076–83
   PubMed Web of Science ®Google Scholar
• Eilber FC, Rosen G, Eckardt J, Forscher C, Nelson SD, Selch M, et al. Treatment-induced pathologic necrosis: A predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol 2001;19:3203–9
   PubMed Web of Science ®Google Scholar
• Jakob J, von Rege I, Weiss C, Hohenberger P. Impact of hyperthermic isolated limb perfusion on tumour oxygenation in soft tissue sarcoma. Int J Hyperthermia 2012;28:591–6
   PubMed Web of Science ®Google Scholar
• Andreou D, Fehlberg S, Tiedke C, Niethard M, Tunn PU. Revolutionizing the treatment of locally advanced extremity soft tissue sarcomas: A review on TNFα-based isolated limb perfusion. Eur Surg 2009;41:176–88
   Web of Science ®Google Scholar
• Schmidt RA, Conrad EU III, Collins C, Rabinovitch P, Finney A. Measurement and prediction of the short-term response of soft tissue sarcomas to chemotherapy. Cancer 1993;72:2593–601
   PubMed Web of Science ®Google Scholar
• Picci P, Rougraff BT, Bacci G, Neff JR, Sangiorgi L, Cazzola A, et al. Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities. J Clin Oncol 1993;11:1763–9
   PubMed Web of Science ®Google Scholar
• Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002;20:776–90
   PubMed Web of Science ®Google Scholar
• Grabellus F, Kraft C, Sheu-Grabellus SY, Bauer S, Podleska LE, Lauenstein TC, et al. Tumor vascularization and histopathologic regression of soft tissue sarcomas treated with isolated limb perfusion with TNF-alpha and melphalan. J Surg Oncol 2011;103:371–9
   PubMed Web of Science ®Google Scholar
• Lucas DR, Kshirsagar MP, Biermann JS, Hamre MR, Thomas DG, Schuetze SM, et al. Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: Clinicopathological correlation. Oncologist 2008;13:451–8
   PubMed Web of Science ®Google Scholar
• Andreou D, Werner M, Pink D, Traub F, Schuler M, Gosheger G, et al. Prognostic relevance of the mitotic count and the amount of viable tumour after neoadjuvant chemotherapy for primary, localised, high-grade soft tissue sarcoma. Br J Cancer 2015;112:455–60
   PubMed Web of Science ®Google Scholar
• Coindre JM, Nguyen BB, Goussot JF, de Mascarel I, Maree D, de Mascarel A, et al. Modifications histologiques aprés chimiothérapie des sarcomes des tissus mous de l'adulte [Histological changes after chemotherapy of soft tissue sarcomas in the adult]. Ann de Pathol 1985;5:95–9
   PubMed Web of Science ®Google Scholar
• Plaat BE, Molenaar WM, Mastik MF, Koudstaal J, van den Berg E, Koops HS, et al. Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in patients with locally advanced soft tissue sarcomas: Treatment response and clinical outcome related to changes in proliferation and apoptosis. Clin Cancer Res 1999;5:1650–7
   PubMed Web of Science ®Google Scholar
• Salzer-Kuntschik M, Delling G, Beron G, Sigmund R. Morphological grades of regression in osteosarcoma after polychemotherapy – study COSS 80. J Cancer Res Clin Oncol 1983;106:S21–4
   PubMed Web of Science ®Google Scholar
• Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, de Mascarel A, et al. Soft-tissue sarcomas of adults: Study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984;33:37–42
   PubMed Web of Science ®Google Scholar
• Perkins NJ, Schisterman EF. The inconsistency of ‘optimal’ cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 2006;163:670–5
   PubMed Web of Science ®Google Scholar
• Fletcher C, Bridge J, Hogendoorn P, Mertens F. WHO classification of tumours of soft tissue and bone. Lyon: International Agency for Research on Cancer; 2013
   Google Scholar
• Deroose JP, Eggermont AM, van Geel AN, Burger JW, den Bakker MA, de Wilt JH, et al. Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas. J Clin Oncol 2011;29:4036–44
   PubMed Web of Science ®Google Scholar
• Jakob J, Tunn PU, Hayes AJ, Pilz LR, Nowak K, Hohenberger P. Oncological outcome of primary non-metastatic soft tissue sarcoma treated by neoadjuvant isolated limb perfusion and tumor resection. J Surg Oncol 2014;109:786–90
   PubMed Web of Science ®Google Scholar
• Pennacchioli E, Deraco M, Mariani L, Fiore M, Mussi C, Collini P, et al. Advanced extremity soft tissue sarcoma: Prognostic effect of isolated limb perfusion in a series of 88 patients treated at a single institution. Ann Surg Oncol 2007;14:553–9
   PubMed Web of Science ®Google Scholar
• Daugaard S, von Glabbeke M, Schiodt T, Mouridsen HT. Histopathological grade and response to chemotherapy in advanced soft tissue sarcomas. Eur J Cancer 1993;29A:811–13
   PubMed Web of Science ®Google Scholar
• Joensuu H, Vehtari A, Riihimaki J, Nishida T, Steigen SE, Brabec P, et al. Risk of recurrence of gastrointestinal stromal tumour after surgery: An analysis of pooled population-based cohorts. Lancet Oncol 2012;13:265–74
   PubMed Web of Science ®Google Scholar
• Hasegawa T, Yamamoto S, Nojima T, Hirose T, Nikaido T, Yamashiro K, et al. Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas. Hum Pathol 2002;33:111–15
   PubMed Web of Science ®Google Scholar
• Deyrup AT, Weiss SW. Grading of soft tissue sarcomas: The challenge of providing precise information in an imprecise world. Histopathology 2006;48:42–50
   PubMed Web of Science ®Google Scholar
• Huth JF, Mirra JJ, Eilber FR. Assessment of in vivo response to preoperative chemotherapy and radiation therapy as a predictor of survival in patients with soft-tissue sarcoma. Am J Clin Oncol 1985;8:497–503
   PubMed Web of Science ®Google Scholar
• Demicheli R, Retsky MW, Hrushesky WJ, Baum M, Gukas ID. The effects of surgery on tumor growth: A century of investigations. Ann Oncol 2008;19:1821–8
   PubMed Web of Science ®Google Scholar
• Khanna C, Hunter K. Modeling metastasis in vivo. Carcinogenesis 2005;26:513–23
   PubMed Web of Science ®Google Scholar
• Italiano A, Delva F, Mathoulin-Pelissier S, Le Cesne A, Bonvalot S, Terrier P, et al. Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: A multivariate analysis of the French Sarcoma Group Database. Ann Oncol 2010;21:2436–41
   PubMed Web of Science ®Google Scholar
• Woll PJ, Reichardt P, Le Cesne A, Bonvalot S, Azzarelli A, Hoekstra HJ, et al. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): A multicentre randomised controlled trial. Lancet Oncol 2012;13:1045–54
   PubMed Web of Science ®Google Scholar